BioLink
Yuan Ding currently holds the position of Strategic Development at BioLink since February 2024. Prior experience includes roles as Senior Associate and Associate at Matrix from September 2020 to October 2023. Yuan completed an MBA at Yale School of Management from August 2018 to June 2020. Additional experiences consist of summer internships at Cybrexa Therapeutics and Pivotal bioVenture Partners, where focus was on oncology biotech and life science investments, respectively. Previous positions also include being a Blavatnik Associate at Yale Office of Cooperative Research and a Venture Capital Intern at Highlight Capital. Yuan's early career features a role as a Private Equity Associate at New Access Capital and a Management Trainee at AstraZeneca. Educational background includes a Bachelor of Science in Pharmaceutical Science with a minor in Economics from Fudan University, complemented by an exchange program at the National University of Singapore in 2014.
This person is not in any teams
BioLink
Bio-Link is a high-tech group enterprise that provides process solutions for the life science industry. We focus on the R&D and manufacturing of equipment and consumables in the production of recombinant protein drugs, vaccines, antibody drugs, cell therapy, gene therapy, and other biological products. Our bioprocessing products cover process units such as upstream cell culture, one-time stock solution, downstream chromatography, tertiary filtration, and hydration products, as well as process development services. As a professional lifescience company, Bio-Link is committed to continuously providing customers with high-quality innovative products and solutions. "Link to enable biotechnologies", our vision is to create an efficient, safe, and competitive biopharmaceutical supply chain ecosystem for our customers.